Jillian B. Thomsen, SVP & Chief Accounting Officer at NEKTAR THERAPEUTICS (NKTR), sold 1,367 shares at $19.67 ($27K) on 2020-08-17, disclosed to the SEC on 2020-08-19.
Seasonal sale ($27k) by SVP & Chief Accounting Officer — this insider has traded NKTR in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2022-08-17 | $10K | — | Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |